Huili Xu Selected Research

tryptoline (tetrahydronorharmane)

12/2020

Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huili Xu Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 11/2004
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2004
1	Alzheimer Disease (Alzheimer's Disease) 12/2020
1	Giant Cell Tumor of Tendon Sheath 01/2019
1	Lung Injury 02/2015

Drug/Important Bio-Agent (IBA)

1	MicroRNAs (MicroRNA)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	2,3-trimethylene-4-quinazoloneIBA 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	AcetylcholinesteraseIBA 12/2020
1	tryptoline (tetrahydronorharmane)IBA 12/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2020
1	Epithelial Cell Adhesion MoleculeIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 12/2020
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	Biological ProductsIBA 12/2020
1	CyclodextrinsIBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	CollagenIBA 08/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Free RadicalsIBA 02/2015
1	Oxygen (Dioxygen)IBA 02/2015
1	CytokinesIBA 02/2015
1	Complementary DNA (cDNA)IBA 11/2004

Therapy/Procedure

1	Nanospheres 12/2020
1	Drug Therapy (Chemotherapy) 12/2020
1	Therapeutics 12/2020